Search - tctmd.com

Displaying 301 - 320 of 8219

Sort: Relevancy | Date

Presentation TCT 2016

CardiAQ: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Gian Paolo Ussia

October 31, 2016

Presentation TCT 2016

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

Presenter: Raj Makkar, Lars Sondergaard, Davide Capodanno

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Farzin Beygui

October 31, 2016

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

TCT 260: Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes Insights from the OPEN CTO Registry

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Presenter: Timothy D. Henry, Amit N. Patel

October 31, 2016

Presentation TCT 2016

TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau

October 31, 2016

Presentation TCT 2016

Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis

Presenter: Javier Escaned, Amir Lerman, Keith G. Oldroyd

October 31, 2016

Presentation TCT 2016

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Presenter: Raj Makkar, Lars Sondergaard, John G. Webb

October 31, 2016

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

ABSORB China Clinical Outcomes at 2 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Runlin Gao

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Presenter: Raj Makkar, Lars Sondergaard, Helene Eltchaninoff

October 31, 2016

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Adam C. Salisbury

October 31, 2016

Advertisement

CardiAQ: Design and Clinical Trial Updates

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

TCT 260: Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes Insights from the OPEN CTO Registry

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

TCT 262: Clinical Outcomes of Deferred Revascularization Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data

Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

ABSORB China Clinical Outcomes at 2 Years

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

ABSORB II Clinical Outcomes at 3 Years

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Clinical Risk Assessment and Health Status Goals in the CHIP Population

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content